GoodRx Holdings Inc. (NASDAQ:GDRX), a leading healthcare technology company specializing in prescription drug discounts and ...

That includes the approval of "innovative" drugs like Tryvio for high blood pressure, Neffy for severe allergic reactions and Dupixent for chronic obstructive pulmonary disease (COPD), which all ...

Santa Monica-based prescription medication discount provider GoodRx Holdings Inc. wants its customers and other medication ...

GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Free Report)’s share price gapped down prior to trading on Friday . The stock had previously closed at $4.95, but opened at $4.81. GoodRx shares last traded at ...

At the 2025 JP Morgan Healthcare Conference, GoodRx’s recently appointed CEO Wendy Barnes highlighted the company’s strategic position to address the gaps in the US healthcare landscape.

That's according to new data from drug savings company GoodRx, which examined fill trends and spending patterns for weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

Shares of GoodRx have fallen ~20% over the past year. Amid hopes for growth via direct relationships with pharmaceutical manufacturers, the company may have hit a near-term bottom. GDRX returned ...

It's not a good experience for a consumer to come to GoodRx, who's used to saving 80% and being able to fill their atorvastatin, but go on a brand drug page and see that it's $750, and not have ...

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.